BeiGene Announces Closing of Approximately $2.08 Billion Registered Direct Offering

NEXT STORY
The New England Journal of Medicine Publishes Results from Positive Phase 2b Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for the Treatment of Chronic Plaque Psoriasis
PREV STORY
Nabriva Therapeutics Enters into Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Aeterna Zentaris Continues to Demonstrate Pipeline Expansion – Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism

author_avatar
NASDAQ Market News

Clinical Trial Imaging Market Research Report by Product & Service, by Modality, by Therapeutic area, by End-User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News